Market closed
HOOKIPA Pharma Inc/$HOOK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About HOOKIPA Pharma Inc
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
Ticker
$HOOK
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
85
ISIN
US43906K2096
Website
HOOK Metrics
BasicAdvanced
$18M
-
-$3.47
0.70
-
Price and volume
Market cap
$18M
Beta
0.7
52-week high
$10.50
52-week low
$0.72
Average daily volume
109K
Financial strength
Current ratio
3.272
Quick ratio
2.57
Long term debt to equity
0.631
Total debt to equity
1.709
Interest coverage (TTM)
-22,393.50%
Management effectiveness
Return on assets (TTM)
-22.96%
Return on equity (TTM)
-61.68%
Valuation
Price to revenue (TTM)
0.419
Price to book
0.36
Price to tangible book (TTM)
0.36
Price to free cash flow (TTM)
-0.239
Growth
Revenue change (TTM)
118.32%
Earnings per share change (TTM)
-59.80%
3-year revenue growth (CAGR)
33.55%
3-year earnings per share growth (CAGR)
-46.80%
What the Analysts think about HOOK
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for HOOKIPA Pharma Inc stock.
HOOK Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
HOOK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
HOOK News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for HOOKIPA Pharma Inc stock?
HOOKIPA Pharma Inc (HOOK) has a market cap of $18M as of May 09, 2025.
What is the P/E ratio for HOOKIPA Pharma Inc stock?
The price to earnings (P/E) ratio for HOOKIPA Pharma Inc (HOOK) stock is 0 as of May 09, 2025.
Does HOOKIPA Pharma Inc stock pay dividends?
No, HOOKIPA Pharma Inc (HOOK) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next HOOKIPA Pharma Inc dividend payment date?
HOOKIPA Pharma Inc (HOOK) stock does not pay dividends to its shareholders.
What is the beta indicator for HOOKIPA Pharma Inc?
HOOKIPA Pharma Inc (HOOK) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.